Shimadzu (Asia Pacific) And Rigaku Corporation Announce Strategic Partnership

Add Bookmark

  • ANNOUNCEMENTS

Shimadzu (Asia Pacific) And Rigaku Corporation Announce Strategic Partnership To Advance X-Ray Diffraction Solutions In South Asia’s Pharmaceutical Market

 

Shimadzu (Asia Pacific) is proud to announce a strategic partnership with Rigaku Corporation, a global leader in X-ray diffraction (XRD) and analytical instrumentation, to distribute, install, and support Rigaku’s XRD product line across the pharmaceutical markets of India, Sri Lanka, Pakistan, and Bangladesh.

The pharmaceutical industry in South Asia is undergoing unprecedented growth, with India leading as a global manufacturing powerhouse. This growth has created potential synergistic opportunities for its neighbouring markets, including Sri Lanka, Pakistan, and Bangladesh. Through this partnership, Shimadzu reinforces its commitment to advancing the region’s pharmaceutical sector.

Under the agreement, Shimadzu (Asia Pacific) will distribute and support Rigaku’s advanced XRD systems—including the SmartLab® series and MiniFlex® benchtop diffractometers, offering customers several key benefits:

  • Access to Rigaku’s latest XRD technology for materials characterization, phase analysis, and research & development applications.
  • Localized support through Shimadzu’s certified engineers for pre-sales consultation, installation, and training.
  • Comprehensive after-sales support, including preventive maintenance and calibration.
  • Seamless integration with Shimadzu’s existing portfolio of analytical solutions for the pharmaceutical industry.

 

Rigaku Corporation, with over 70 years of innovation, is a global leader in X-ray analysis, crystallography, and spectroscopy solutions. Its cutting-edge technologies are trusted worldwide across industries such as pharmaceuticals, materials science, energy, forensics, and semiconductors, supporting advancements in research, process control, and quality assurance.

Together, Shimadzu (Asia Pacific) and Rigaku Corporation aim to strengthen their presence in South Asia’s pharmaceutical market by delivering Total Solutions that address the growing demand for advanced analytical technologies. This partnership is poised to drive innovation, enhance operational efficiency, and contribute to the development of high-quality pharmaceutical products that benefit global healthcare.